Insights into adult atopic dermatitis heterogeneity derived from circulating biomarker profiling in patients with moderate-to-severe disease - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34003519/

doi: 10.1111/exd.14389. Online ahead of print. 1 Eli Lilly and Company, Indianapolis, IN, USA. 2 Department of Dermatology, Oregon Health & Science University, Portland, OR, USA. 3 Department of Dermatology, The George Washington University School of Medicine and Health Sciences, Washington, DC, USA. 4 Forward Clinical Trials, Inc, Tampa, FL, USA.